公开(公告)号：US11834418B2

公开(公告)日：2023-12-05

申请号：US17127231

申请日：2020-12-18

申请人： BIOHAVEN THERAPEUTICS LTD.

发明人： Lynn Resnick ,  George T. Topalov ,  Justin K. Belardi ,  James S. Hale ,  Scott S. Harried ,  Charles A. Flentge ,  David A. Mareska

IPC分类号： C07D235/30 ,  C07D413/04 ,  C07D401/04 ,  C07D405/12 ,  C07D403/04 ,  C07D401/12

CPC分类号： C07D235/30 ,  C07D401/04 ,  C07D401/12 ,  C07D403/04 ,  C07D405/12 ,  C07D413/04

摘要： Optionally substituted benzoimidazol-1,2-yl amides, such as compounds of Formula 1 or Formula 2, can be used to treat disorders associated with a Kv7 potassium channel activator. Compositions, medicaments, and dosage forms related to the treatment are also disclosed herein.